Pertussis in Arkansas.
Although the morbidity and mortality due to pertussis has declined, 109 infants and children were diagnosed and reported to the Arkansas Department of Health with pertussis in 1990-1994. Case rates in Arkansas over this five year period were lower than national case rates (0.9/100,000 vs. 1.77/100,000; p < 0.0001) while the case fatality rates were similar. Hospitalization, admissions to the intensive care, and deaths in Arkansas were more commonly demonstrated in children < 1 year of age. Although recent data concerning the safety and efficacy of the acellular vaccines is promising, at this time the primary series should still be given with the whole-cell vaccine until more data becomes available.
Lu
E
E
UAMS/Arkansas Children's Hospital, USA.
Kirby
R S
RS
Schutze
G E
GE
D001131:Arkansas / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D010567:Pertussis Vaccine / Q000008:administration & dosage / Q000009:adverse effects; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000009:adverse effects; D014917:Whooping Cough / Q000453:epidemiology* / Q000517:prevention & control
D010567:Pertussis Vaccine; D014614:Vaccines, Synthetic